| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 401 |  Zymeworks Inc. ZYME🇺🇸USD | $24.04 | -4.22% | +7.71% | $1.77B €1.53B | 458.16K shrs $11.01M | |
| 402 | £161.50 | -6.38% | +1.58% | £1.39B $1.76B · €1.53B | 126.59K shrs £20.44M | ||
| 403 | $3.31 | -12.76% | +16.14% | $1.76B €1.52B | 26.77M shrs $88.73M | ||
| 404 | ¥4.63 | -0.43% | -17.39% | ¥12.74B $1.76B · €1.52B | 143.24M shrs ¥663.19M | ||
| 405 | $15.78 | -4.77% | +6.94% | $1.74B €1.51B | 1.73M shrs $27.32M | ||
| 406 | ₹738.40 | +0.12% | +6.19% | ₹145.14B $1.74B · €1.51B | 98.08K shrs ₹72.42M | ||
| 407 | ₹736.95 | +0.17% | +5.98% | ₹144.86B $1.74B · €1.51B | 21.36K shrs ₹15.74M | ||
| 408 | ¥11.29 | -0.96% | -0.67% | ¥12.55B $1.73B · €1.50B | 23.14M shrs ¥261.3M | ||
| 409 | $36.10 | -3.71% | +1.31% | $1.73B €1.50B | 180.66K shrs $6.52M | ||
| 410 | ¥7.10 | -0.70% | +3.27% | ¥12.49B $1.72B · €1.49B | 5.69M shrs ¥40.41M | ||
| 411 | A$2.05 | +1.49% | -8.07% | A$2.65B $1.72B · €1.49B | 3.29M shrs A$6.74M | ||
| 412 | ¥15.90 | +0.32% | +1.25% | ¥12.44B $1.72B · €1.49B | 4.09M shrs ¥65.03M | ||
| 413 | $5.62 | -11.77% | +34.99% | $1.72B €1.49B | 8.9M shrs $50M | ||
| 414 | €30.96 | -0.90% | +6.88% | €1.57B $1.71B | 165.04K shrs €5.11M | ||
| 415 | ¥21.76 | +1.78% | -0.25% | ¥12.34B $1.70B · €1.47B | 5.28M shrs ¥114.92M | ||
| 416 | ¥10.04 | +0.10% | -2.20% | ¥12.21B $1.69B · €1.46B | 6.54M shrs ¥65.68M | ||
| 417 | $28.29 | -1.74% | +4.19% | $1.68B €1.46B | 561.24K shrs $15.88M | ||
| 418 | $4.82 | -6.77% | -10.26% | $1.68B €1.45B | 3.21M shrs $15.46M | ||
| 419 | ¥37.62 | +0.00% | +1.40% | ¥12.13B $1.67B · €1.45B | 2.01M shrs ¥75.58M | ||
| 420 | ¥12.73 | -0.86% | -6.86% | ¥12.1B $1.67B · €1.45B | 13.75M shrs ¥175.04M | ||
| 421 |  uniQure N.V. QURE🇺🇸USD | $26.45 | -5.50% | -7.89% | $1.67B €1.44B | 1.45M shrs $38.29M | |
| 422 | HK$34.82 | -2.95% | +5.33% | HK$13B $1.66B · €1.44B | 2.28M shrs HK$79.49M | ||
| 423 | $15.75 | -5.46% | +5.45% | $1.66B €1.44B | 2.73M shrs $43.07M | ||
| 424 |  Innoviva, Inc. INVA🇺🇸USD | $22.52 | +1.62% | -7.01% | $1.66B €1.44B | 830.31K shrs $18.7M | |
| 425 | ¥8.96 | +1.01% | -1.91% | ¥12.02B $1.66B · €1.44B | 3.48M shrs ¥31.14M | ||
| 426 | ¥12.92 | -0.77% | +10.08% | ¥11.99B $1.65B · €1.43B | 10.32M shrs ¥133.27M | ||
| 427 | $12.87 | -12.45% | +6.93% | $1.65B €1.43B | 1.63M shrs $21.03M | ||
| 428 | HK$31.58 | -7.06% | -58.63% | HK$12.88B $1.65B · €1.43B | 2.53M shrs HK$79.96M | ||
| 429 | ¥26.60 | -1.23% | +12.40% | ¥11.88B $1.64B · €1.42B | 8.29M shrs ¥220.41M | ||
| 430 | ¥24.82 | +1.18% | +11.33% | ¥11.86B $1.64B · €1.42B | 41.96M shrs ¥1.04B | ||
| 431 |  Biohaven Ltd. BHVN🇺🇸USD | $10.80 | -5.26% | +6.63% | $1.63B €1.41B | 2.03M shrs $21.97M | |
| 432 | ¥20.56 | +0.93% | -1.96% | ¥11.76B $1.62B · €1.41B | 1.31M shrs ¥26.91M | ||
| 433 | $8.23 | -8.96% | +46.31% | $1.62B €1.40B | 6.67M shrs $54.93M | ||
| 434 | NT$198.50 | -1.24% | -0.79% | NT$52.17B $1.62B · €1.40B | 2.54M shrs NT$503.67M | ||
| 435 | ¥12.17 | +0.75% | -0.67% | ¥11.7B $1.62B · €1.40B | 9.43M shrs ¥114.74M | ||
| 436 | ¥9.75 | +0.72% | +6.36% | ¥11.69B $1.61B · €1.40B | 9.25M shrs ¥90.17M | ||
| 437 | ₺84.00 | -2.44% | -9.05% | ₺57.56B $1.61B · €1.40B | 2.96M shrs ₺248.68M | ||
| 438 | £130.30 | -6.93% | +14.12% | £1.27B $1.61B · €1.39B | 1.96M shrs £255.1M | ||
| 439 | ¥22.24 | +1.09% | +8.12% | ¥11.64B $1.61B · €1.39B | 5.33M shrs ¥118.47M | ||
| 440 | $17.20 | -5.91% | +5.58% | $1.61B €1.39B | 13.26K shrs $228.04K | ||
| 441 | $35.37 | -6.38% | +4.44% | $1.6B €1.38B | 461.28K shrs $16.32M | ||
| 442 | ¥28.80 | -2.67% | -2.89% | ¥11.52B $1.59B · €1.38B | 13.28M shrs ¥382.55M | ||
| 443 | $26.64 | -1.99% | -2.16% | $1.58B €1.37B | 1.45M shrs $38.5M | ||
| 444 | $5.50 | -6.62% | -3.06% | $1.58B €1.37B | 1.31M shrs $7.22M | ||
| 445 | ¥25.55 | -0.82% | +11.78% | ¥11.32B $1.56B · €1.35B | 7.12M shrs ¥181.98M | ||
| 446 |  Novavax, Inc. NVAX🇺🇸USD | $9.49 | -6.87% | +5.11% | $1.56B €1.35B | 4.56M shrs $43.31M | |
| 447 | $108.67 | -5.36% | +16.50% | $1.56B €1.35B | 369.44K shrs $40.15M | ||
| 448 | HK$14.42 | +2.27% | -1.56% | HK$12.13B $1.55B · €1.34B | 1.93M shrs HK$27.87M | ||
| 449 | ¥9.25 | +0.54% | +0.11% | ¥11.24B $1.55B · €1.34B | 24.34M shrs ¥225.15M | ||
| 450 | €4.57 | +0.11% | -2.26% | €1.42B $1.55B | 210K shrs €959.71K | ||
| 451 | $26.71 | -4.44% | -22.06% | $1.55B €1.34B | 573.78K shrs $15.33M | ||
| 452 | ¥42.26 | -3.65% | +7.10% | ¥11.16B $1.54B · €1.33B | 6.74M shrs ¥284.67M | ||
| 453 | $17.34 | -3.77% | +6.53% | $1.54B €1.33B | 2.7M shrs $46.86M | ||
| 454 | $16.08 | -6.78% | +6.80% | $1.52B €1.32B | 1.02M shrs $16.39M | ||
| 455 | ₹1032.50 | -0.32% | +5.12% | ₹126.73B $1.52B · €1.32B | 35.63K shrs ₹36.79M | ||
| 456 | ₹1210.65 | -2.19% | -3.97% | ₹126.65B $1.52B · €1.32B | 14.17K shrs ₹17.16M | ||
| 457 | ₹1209.90 | -2.29% | -2.40% | ₹126.58B $1.52B · €1.32B | 207.73K shrs ₹251.33M | ||
| 458 | ₹1030.95 | -0.48% | +4.78% | ₹126.54B $1.52B · €1.32B | 52.94K shrs ₹54.58M | ||
| 459 | ¥12.35 | +0.08% | +4.93% | ¥10.98B $1.52B · €1.31B | 8.98M shrs ¥110.95M | ||
| 460 | $14.64 | -4.19% | +26.78% | $1.51B €1.31B | 1.63M shrs $23.91M | ||
| 461 | R 0.33 | +0.68% | +0.18% | R 28.01B $1.51B · €1.31B | 1.59M shrs R 51.97M | ||
| 462 | ¥12.68 | +0.40% | +8.46% | ¥10.92B $1.51B · €1.30B | 8.42M shrs ¥106.78M | ||
| 463 | $10.83 | +1.50% | +8.64% | $1.5B €1.30B | 2.5M shrs $27.11M | ||
| 464 |  HitGen Inc. 688222.SS🇨🇳CNY | ¥26.91 | +1.66% | +8.39% | ¥10.78B $1.49B · €1.29B | 13.49M shrs ¥362.94M | |
| 465 | $13.32 | -6.92% | +9.65% | $1.48B €1.28B | 1.69M shrs $22.48M | ||
| 466 |  GH Research PLC GHRS🇺🇸USD | $21.43 | -7.83% | +11.90% | $1.47B €1.27B | 327.59K shrs $7.02M | |
| 467 | NT$371.50 | +2.34% | -3.64% | NT$47.32B $1.47B · €1.27B | 1.32M shrs NT$489.77M | ||
| 468 |  AnaptysBio, Inc. ANAB🇺🇸USD | $50.37 | -2.52% | +10.10% | $1.47B €1.27B | 513.49K shrs $25.86M | |
| 469 | $8.65 | -5.46% | -5.91% | $1.46B €1.26B | 1.33M shrs $11.48M | ||
| 470 | ¥4.16 | +0.24% | -4.53% | ¥10.55B $1.46B · €1.26B | 26.1M shrs ¥108.57M | ||
| 471 |  AtaiBeckley Inc. ATAI🇺🇸USD | $3.95 | -12.22% | +19.02% | $1.45B €1.26B | 9.16M shrs $36.2M | |
| 472 | HK$215.40 | +4.66% | -19.04% | HK$11.27B $1.44B · €1.25B | 52.9K shrs HK$11.39M | ||
| 473 | $30.28 | -2.04% | +20.54% | $1.44B €1.25B | 570.33K shrs $17.27M | ||
| 474 | $28.29 | -1.63% | +8.39% | $1.44B €1.25B | 276.93K shrs $7.83M | ||
| 475 | HK$56.50 | -0.62% | -6.15% | HK$11.24B $1.44B · €1.25B | 853.3K shrs HK$48.21M | ||
| 476 | $26.95 | +0.00% | — | $1.43B €1.24B | 1.8M shrs $48.54M | ||
| 477 | ¥12.55 | -0.16% | +0.24% | ¥10.35B $1.43B · €1.24B | 7.48M shrs ¥93.86M | ||
| 478 | ¥24.00 | +2.92% | -3.93% | ¥10.35B $1.43B · €1.24B | 4.43M shrs ¥106.43M | ||
| 479 | ¥17.14 | +1.48% | -0.82% | ¥10.3B $1.42B · €1.23B | 4.25M shrs ¥72.78M | ||
| 480 | HK$10.48 | +2.64% | +9.54% | HK$11.06B $1.42B · €1.23B | 2.06M shrs HK$21.64M | ||
| 481 | $30.35 | -8.28% | +2.25% | $1.41B €1.22B | 626.02K shrs $19M | ||
| 482 | ¥17.59 | -0.62% | +21.08% | ¥10.2B $1.41B · €1.22B | 14.7M shrs ¥258.65M | ||
| 483 | HK$65.50 | -3.68% | +9.95% | HK$10.98B $1.41B · €1.22B | 27.6K shrs HK$1.81M | ||
| 484 |  Septerna, Inc. SEPN🇺🇸USD | $31.15 | -0.70% | -5.36% | $1.4B €1.22B | 205.07K shrs $6.39M | |
| 485 | ¥3235.00 | +1.25% | +0.31% | ¥208.99B $1.40B · €1.21B | 98.4K shrs ¥318.32M | ||
| 486 | ₩43750.00 | -4.48% | -0.72% | ₩1.94T $1.40B · €1.21B | 114.16K shrs ₩4.99B | ||
| 487 | HK$29.38 | +0.27% | +5.90% | HK$10.88B $1.39B · €1.21B | 1.12M shrs HK$33.04M | ||
| 488 | $16.37 | -5.70% | +15.98% | $1.38B €1.20B | 949.04K shrs $15.54M | ||
| 489 |  Ardelyx, Inc. ARDX🇺🇸USD | $5.56 | +2.96% | -16.50% | $1.37B €1.19B | 4.58M shrs $25.44M | |
| 490 | ¥5779.00 | -0.70% | +2.52% | ¥202.95B $1.36B · €1.18B | 97.6K shrs ¥564.03M | ||
| 491 | Fr 36.40 | -3.45% | +22.00% | Fr 1.2B $1.35B · €1.17B | 52.68K shrs Fr 1.92M | ||
| 492 | $24.27 | -4.45% | +12.87% | $1.34B €1.16B | 428.33K shrs $10.4M | ||
| 493 |  Immatics N.V. IMTX🇺🇸USD | $9.79 | -3.83% | -0.61% | $1.34B €1.16B | 1.03M shrs $10.13M | |
| 494 | ₹255.25 | +2.45% | +8.39% | ₹111.41B $1.34B · €1.16B | 2.95M shrs ₹752.38M | ||
| 495 | NT$658.00 | +2.02% | +8.76% | NT$43.13B $1.34B · €1.16B | 137.85K shrs NT$90.7M | ||
| 496 | ₹255.15 | +2.39% | +6.19% | ₹111.36B $1.34B · €1.16B | 867.59K shrs ₹221.37M | ||
| 497 | ¥39.66 | -6.06% | -4.84% | ¥9.63B $1.33B · €1.15B | 28.2M shrs ¥1.12B | ||
| 498 | ¥1712.50 | -0.26% | +2.65% | ¥197.77B $1.33B · €1.15B | 406.5K shrs ¥696.13M | ||
| 499 | ₹4765.70 | +1.34% | -2.38% | ₹109.91B $1.32B · €1.14B | 2.31K shrs ₹10.98M | ||
| 500 | ₹4770.60 | +1.29% | -2.10% | ₹109.87B $1.32B · €1.14B | 327 shrs ₹1.56M |
Browse by Country
Europe
Asia